Wordt geladen...
Targeting mTOR in Glioblastoma: Rationale and Preclinical/Clinical Evidence
The mechanistic target of rapamycin (mTOR) drives several physiologic and pathologic cellular processes and is frequently deregulated in different types of tumors, including glioblastoma (GBM). Despite recent advancements in understanding the molecular mechanisms involved in GBM biology, the surviva...
Bewaard in:
| Gepubliceerd in: | Dis Markers |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Hindawi
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6312595/ https://ncbi.nlm.nih.gov/pubmed/30662577 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/9230479 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|